Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records

被引:5
作者
Campbell, Anne [1 ]
Bailey, Steffani R. [2 ]
Hoffman, Kim A. [3 ]
Ponce-Terashima, Javier [4 ]
Fankhauser, Katie [2 ]
Marino, Miguel [2 ,3 ]
McCarty, Dennis [3 ]
机构
[1] Queens Univ, Sch Social Sci Educ & Social Work, Belfast, ME, North Ireland
[2] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA
[3] Portland State Univ, Sch Publ Hlth, Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd CB669, Portland, OR 97230 USA
[4] Case Western Reserve Univ, Univ Hosp, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Substance use disorder; cannabis use disorder; electronic health records; psychiatric disorders; MAJOR DEPRESSIVE DISORDER; ANXIETY DISORDERS; MENTAL-HEALTH; RISK; METAANALYSIS; PREVALENCE; DEPENDENCE; PSYCHOSIS; MARIJUANA; SYMPTOMS;
D O I
10.1080/02791072.2020.1747665
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Data from a large network of community health centers connected via a single electronic health record (EHR) system examined associations between psychiatric disorders and documentation of a cannabis-related disorder among patients with reported cannabis use. Participants were adults who had at least one ambulatory visit at a clinic in three states between 1/1/2012 and 12/31/2016 and had either 1) a documented cannabis-related disorder indicated by an ICD-9/10 code on the problem list or encounter list or 2) documentation of cannabis use in the EHR social history section. Clinics included 101,405 patients with either cannabis use recorded in the social history of the EHR (n = 71,660) or a cannabis-related disorder documented in the encounter or problem list (n = 29,745). GEE logistic regression modeling estimated adjusted odds ratios (aOR). Odds of patients having cannabis-related disorder recorded on the encounter or problem list were higher for individuals with depression (aOR = 1.08, 95% CI: 1.04-1.13), anxiety (aOR = 1.16, CI: 1.11-1.21) and bipolar disorder (aOR = 1.16, CI: 1.10-1.23). A diagnosis of schizophrenia increased the odds of a cannabis-related disorder by 62% (aOR = 1.62, CI: 1.48- 1.78). Primary care providers should routinely screen for and document cannabis-related disorders and psychiatric disorders.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 39 条
  • [1] [Anonymous], 2000, AMERICAS HLTH CARE S, DOI DOI 10.17226/9612
  • [2] [Anonymous], 2018, Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068
  • [3] Cannabis Use and Risk of Psychiatric Disorders Prospective Evidence From a US National Longitudinal Study
    Blanco, Carlos
    Hasin, Deborah S.
    Wall, Melanie M.
    Florez-Salamanca, Ludwing
    Hoertel, Nicolas
    Wang, Shuai
    Kerridge, Bradley T.
    Olfson, Mark
    [J]. JAMA PSYCHIATRY, 2016, 73 (04) : 388 - 395
  • [4] Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders
    Brook, DW
    Brook, JS
    Zhang, CS
    Cohen, P
    Whiteman, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (11) : 1039 - 1044
  • [5] The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
    Di Forti, Marta
    Quattrone, Diego
    Freeman, Tom P.
    Tripoli, Giada
    Gayer-Anderson, Charlotte
    Quigley, Harriet
    Rodriguez, Victoria
    Jongsma, Hannah E.
    Ferraro, Laura
    La Cascia, Caterina
    La Barbera, Daniele
    Tarricone, Ilaria
    Berardi, Domenico
    Szoke, Andrei
    Arango, Celso
    Tortelli, Andrea
    Velthorst, Eva
    Bernardo, Miguel
    Del-Ben, Cristina Marta
    Menezes, Paulo Rossi
    Selten, Jean-Paul
    Jones, Peter B.
    Kirkbride, James B.
    Rutten, Bart P. F.
    de Haan, Lieuwe
    Sham, Pak C.
    van Os, Jim
    Lewis, Cathryn M.
    Lynskey, Michael
    Morgan, Craig
    Murray, Robin M.
    [J]. LANCET PSYCHIATRY, 2019, 6 (05): : 427 - 436
  • [6] Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
    Di Forti, Marta
    Marconi, Arianna
    Carra, Elena
    Fraietta, Sara
    Trotta, Antonella
    Bonomo, Matteo
    Bianconi, Francesca
    Gardner-Sood, Poonam
    O'Connor, Jennifer
    Russo, Manuela
    Stilo, Simona A.
    Marques, Tiago Reis
    Mondelli, Valeria
    Dazzan, Paola
    Pariante, Carmine
    David, Anthony S.
    Gaughran, Fiona
    Atakan, Zerrin
    Iyegbe, Conrad
    Powell, John
    Morgan, Craig
    Lynskey, Michael
    Murray, Robin M.
    [J]. LANCET PSYCHIATRY, 2015, 2 (03): : 233 - 238
  • [7] Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
    Di Forti, Marta
    Sallis, Hannah
    Allegri, Fabio
    Trotta, Antonella
    Ferraro, Laura
    Stilo, Simona A.
    Marconi, Arianna
    La Cascia, Caterina
    Marques, Tiago Reis
    Pariante, Carmine
    Dazzan, Paola
    Mondelli, Valeria
    Paparelli, Alessandra
    Kolliakou, Anna
    Prata, Diana
    Gaughran, Fiona
    David, Anthony S.
    Morgan, Craig
    Stahl, Daniel
    Khondoker, Mizanur
    MacCabe, James H.
    Murray, Robin M.
    [J]. SCHIZOPHRENIA BULLETIN, 2014, 40 (06) : 1509 - 1517
  • [8] Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States
    ElSohly, Mahmoud A.
    Mehmedic, Zlatko
    Foster, Susan
    Gon, Chandrani
    Chandra, Suman
    Church, James C.
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (07) : 613 - 619
  • [9] *EUR MON CTR DRUGS, 2011, ANN REP STAT DRUGS P
  • [10] *EUR MON CTR DRUGS, 2015, CHAR FREQ HIGH RISK